Answers are grounded in this paper and cite their sources.
Prospective cohort study outlines health surveillance in over 500,000 Taiwanese adults, highlighting pathways between lifestyle biomarkers and chronic disease.
Chronic non-communicable diseases (NCD) that manifest primarily later in life, such as cancer, cardiovascular disease, diabetes and chronic obstructive pulmonary disease, account for nearly two-thirds of deaths in the world.1 Over the past few decades, the burden of chronic NCD in the USA and worldwide has increased dramatically as a consequence of ageing populations and unhealthy lifestyle changes, including overweight and obesity, lack of physical activity, unhealthy diet habits, cigarette smoking and excessive alcohol drinking. An important feature of these chronic NCD is that they are not independent of each other, but instead often clustered together. A recent systematic review of literature found that multimorbidity (the coexistence of multiple chronic diseases) affects more than half of the elderly population.2 The clustering of chronic NCD could be mediated by shared risk factors and/or through common biological pathways. Deciphering the complex relationship between chronic NCD, identifying shared risk factors and finding common biological links would have profound impact on disease prevention and therapy. There is a critical need for large prospective cohorts capable of addressing the relationship between chronic diseases, lifestyle factors, biomarkers and cancer incidence and mortality. The Taiwan MJ Cohort builds upon a large database and biorepository of healthy individuals undergoing a health screening programme in Taiwan conducted by MJ Group, the largest health management institute in Asia. This is a unique cohort, the most representative of Chinese in the literature, and is best suited for dissecting the complex relationship between chronic diseases and cancer and identifying modifiable risk factors and biomarkers for chronic diseases and cancer. To date there has not been a cohort with such a large sample size with extensive medical tests for each participant and repeated questionnaire and medical tests for half of the participants. This cohort will have significant impact on multiple aspects and will: establish a unique rich resource for cancer epidemiology study; dissect complex and temporal relationship between chronic diseases and cancer; provide evidence-based recommendations for lifestyle and behavioural changes for the reduction of chronic diseases and cancer; identify risk factors and common biological pathways for chronic diseases and cancer; identify high-risk individuals for common cancers; and identify minimally invasive early detection markers for common cancers. The cohort was established by MJ Health Management Institution, which is a private fee-for-service company offering comprehensive health screening programmes. MJ is known for its efficiency in adopting an automated ‘assembly-line’ type of operation, completing the whole screening and medical evaluation process within a few hours in the morning. By the lunch hour, the full report is ready and a multidisciplinary team offers interpretation of screening results and individualized counselling for any lifestyle changes or follow-up action needed. The cohort was established as part of the health screening data management process, and has enrolled participants since 1994. As each individual completed a health history questionnaire, multi-phasic blood panel and laboratory tests like lung function, cardiogram, urinalysis and stool tests, these data were used primarily to facilitate the health management of the participants. The data were collated from different sources to provide the medical doctor with the necessary information to summarize the findings at the conclusion of the screening session. The MJ Cohort is an open (dynamic) cohort with no ending date, and we have updated our cohort to 2011. As of 2011, the cohort consisted of 593 215 apparently healthy individuals who participated in a standard medical screening programme run by a private firm (MJ Health Management Institution, Taipei, Taiwan). The cohort members were aged 20 years and older, coming from all over the country. All participants paid to become members and paid additionally to have health examinations, and may appear to be of higher socioeconomic status than the average population. However, many members paid for their parents and relatives, who could have been in different or lower socioeconomic classes. MJ also accepted individuals paid by different companies, constituting occupational cohorts. There were four clinics located in the northern (Taipei), north-west (Taoyuan), central (Taichung) and southern (Kaohsiung) parts of Taiwan. All four clinics used identical screening procedures with the same models of instruments, and results were centrally managed and stored. All the procedures among four clinics were approved by ISO 9001. Every participant signed a consent form authorizing MJ Health Management Institution to process the data generated from medical screening. Ethical reviews of this study were processed and approved at the National Health Research Institutes and at China Medical University Hospital. All participants were encouraged to visit on a yearly basis (Figure 1); the same questionnaires were filled out at every visit (Figure 2), but results from the initial visit only were used. During the period from 1994 to 2011, the questions were little changed but some new questions were added after 2011. When analysing the questionnaires, we harmonized all the data. The 17-year study period from 1994 to 2011 yielded 5.97 million person-years of follow-up, with an average follow-up of 10.1 years [standard deviation (SD) 4.97]. Every individual’s identification number was matched with the National Death file and the National Cancer Registry file between 1994 and 2011. Taiwan has the most completed National Death file and National Cancer Registry when compared with China and the USA. Computer files of the death certification system and cancer registry are routinely matched against profiles of members of the MJ Cohort. Thus, data on the vital status of all cohort members and the causes of all deaths are complete. Details of specific mortality and cancer incidence are shown in Appendix Table 1 (available as Supplementary data at IJE online). Domains and measures assessed in the MJ Cohort Domains and measures assessed in the MJ Cohort Flow showing the timing of recruitment of study subjects between 1994 and 2011. Flow diagram showing repeat visits by decreasing number of study subjects. (Chen C, Tsai M, Wen C. Extending Colorectal Cancer Screening to Persons Aged 40 to 49 Years With Immunochemical Fecal Occult Blood Test: A Prospective Cohort Study of 513,283 Individuals. Journal of clinical gastroenterology 2016; 50: 761–8). Participants had a series of medical tests for blood, urine, stool, body measurements, functional tests, physical examination, medical history and lifestyle information (questionnaire). All measures used in this cohort are listed in Table 1. The baseline characteristics of the cohort are listed in Table 2. Characteristics of the cohort Characteristics of the cohort Every participant completed a self-administered questionnaire (100 questions) at the time of screening for health history, asking for demographic, socioeconomic, medical, nutrition and lifestyle (smoking, drinking, betel quid chewing and physical activity) information, as well as personal and family histories of major chronic diseases. Smokers, including current and ex-smokers, were those who self-reported to smoke regularly (exceeding 100 cigarettes in their life time). Drinking was defined as drinking alcohol three times or more a week and two or more drinks each time. Chewers were those who self-reported having had the habit of consuming betel quid regularly at the initial intake of the medical screening. Education levels were classified as low education levels (middle school or below) and high education levels (high school, junior college and college or above). Leisure-time physical activity (LTPA) was defined in a previous report,3 classifying individuals by exercise volume (calculated from self-reported exercise frequency, duration and intensity) into inactive, low active [90 min/week or 15 min/day or 3.75-7.49 metabolic equivalents (MET)-h/week] and fully active (≥ 150 min/week or 30 min/day or ≥ 7.5 MET-h/week). A more detailed description has been documented elsewhere.3 Identical screening procedures with the same model of instruments were used in all four clinics and results were centrally managed and stored. Blood samples were drawn with heparin as an anticoagulant, and serum samples were preserved at -20°C. Overnight fasting blood was collected and analysed (Hitachi 7150 auto-analysers, Tokyo, Japan), with serum creatinine analysed by the uncompensated Jaffe method with an alkaline picrate kinetic test.4 Likewise, the fasting glucose level was measured on the same autoanalyser. Glomerular filtration rate (GFR) was estimated the from serum creatinine level by using the 4-variable Modification of Diet in Renal Disease (MDRD) Study equation.5,6 The automated OC-sensor test (Eiken Chemical Company, Tokyo, Japan), quantifying antibodies specific for human haemoglobin, has been used unchanged since the start of the study in 1994 through 2011.7 Carriage statuses of hepatitis B surface antigen (HBsAg) and antibody against hepatitis C virus (anti-HCV) were determined using enzyme immunoassay kits. The fecal immunochemical test (FIT) is a quantitative measurement of haemoglobin with 100 ng/ml as cut-point for positive. FIT was adopted on day 1 at MJ in 1994, as an automated OC-sensor method developed by Eiken Chemical Company, Tokyo, Japan, quantifying antibodies specific for human haemoglobin. The Roche Miditron M semi-automated computer-assisted urinalysis system (Combur-10 test M dipstick, Basel, Switzerland) was used for urinary protein. The result was reported as negative or normal and minimal (trace or one plus, equivalent to micro-albuminuria). Body weight and height were measured by an auto-anthropometer, Nakamura KN-5000A (Nakamura, Tokyo, Japan). Body weight was measured to the nearest 0.1 kg with participants when they were barefoot and wearing light indoor clothing. Body height was recorded to the nearest 0.1 cm. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in metres. Waist circumference (to the nearest mm) was measured at the midpoint between the lower margin of the rib cage and the crest of the ilium. Hip circumference (to the nearest mm) was measured around the pelvis at the point of maximal protrusion of the buttocks. Blood pressure was measured twice on the right arm with the subject in a sitting position, after 5 min of rest, using a computerized auto-mercury-sphygmomanometer, Citizen CH-5000 (Citizen, Tokyo, Japan). Resting heart rate was measured by electrocardiography (ECG) in a lying position after a 5-minute resti. Some participants at the earlier stages operated by the MJ Health Management Institution did not receive questionnaires, and some data were therefore missing for specific elements: physical activity (23%), smoking (20%), users of Chinese herbal medicine (13%), awareness of chronic kidney disease (13%) and educational levels (17%). All other data, including serum creatinine, glomerular filtration rate, urine protein test, blood pressure, body mass index (BMI) and blood glucose, were more than 99% complete for 593 215 individuals, and therefore prevalence and mortality risks of diseases were minimally affected by the missing data. Taiwan has a computer file for all deaths of citizens, which are coded from death certificates. Through linking the unique identification number with the computerized file, 27 155 deaths were identified from this cohort as of 2011. Causes of death–classified according to International Classification of diseases (ICD-9)—consisted of all causes (001-998), cardiovascular diseases (390-459), expanded cardiovascular diseases [cardiovascular disease plus diabetes (250) plus kidney diseases (580-589)] and non-cardiovascular diseases (all causes minus expanded cardiovascular diseases). To date, almost 30 published journal articles have been derived from the MJ Cohort on topics including cancer,8–12 hepatocellular carcinoma,13 cardiovascular disease,14 chronic kidney disease,14–18 metabolic syndrome,19 trace proteinuria,20 bilirubin,11 high serum uric acid,21,22 high serum iron,10 tuberculosis,23 estimated glomerular filtration rate (eGFR),24 physical activity,3,22,25–27 smoking,23 betel quid chewing,8,9 adiposity,28,29 sleep30 and suicide.29–31 These publications represent the multidisciplinary nature of the data collection, and a selection of key findings is listed as follows. Compared with individuals in the inactive group, those in the low-volume activity group, who exercised for an average of 15 min a day, had a 3-year longer life expectancy.3 The national prevalence of chronic kidney disease (CKD) was 11.9%, but only 3.5% of participants were aware of their disorder. Prevalence was substantially higher in the group with low socioeconomic status than in the high-status group.15 High serum iron (≥ 120 μg/dl) was associated with a 25% increase in risk for incidence of all cancers and with a 39% increase in risk for mortality from all cancers. The liver [hazard ratio (HR), 2.49; 95% confidence nterval (CI), 1.97−3.16] and the breast (HR, 1.31; 95% CI, 1.01-1.70) were the two major cancer sites where significant cancer risks were observed from serum iron of ≥ 120 μg/dl and ≥140 μg/dl, respectively.10 One-third of smokers chewed (33%) but most of chewers smoked (90%). Risk for all cancer doubled among betel quid chewers (HR = 2.00). In addition to oral cancer, significant increases were seen among chewers for cancer of the oesophagus, liver, pancreas, larynx, lung and all cancers.8 Smokers had very high tuberculosis (TB) mortality, as much as nine times those who had never smoked, but once they quit, the risk reduced substantially and was similar to those who never smoked.23 Participants with a moderate to severe decrease in estimated glomerular filtration rate (eGFR) had increased hazard ratios (HRs) for mortality from all causes (HR = 1.44), cardiovascular disease (HR = 1.90), coronary heart disease (HR = 1.90) and stroke (HR = 2.16) after adjusting for confounders.24 Age, sex, health history, HBV and HCV status, and serum ALT, AST, AFP levels were statistically significant independent predictors of hepatocellular carcinoma risk. Models with transaminase data were best able to predict hepatocellular carcinoma risk even among subjects with unknown or HBV- or HCV-negative infection status.13 In this Asian population, every unit of BMI increase at 25 kg/m2 or above was associated with a 9% increase in relative mortality risk from all causes. The study supports the use of BMI ≥ 25 kg/m2 as a new cut-off point for obesity, rather than BMI ≥ 30 kg/m2.28. There was a J-shaped association between BMI and suicide risk. A high waist-to-hip ratio was associated with an increased risk of suicide.29 There was a reverse J-shaped association between sleep duration and suicide risk. Less than 6 h sleep duration, sleep disturbances and reported use of sleep medicines are markers of suicide risk.20 This cohort has a number of major strengths. First, the cohort’s large sample size, coupled with its longitudinal collection of data, extensive medical test results for each participant and substantial biorepository, make for a resource uniquely suitable for dissecting relationships between chronic diseases and cancer incidence and mortality. No other cohort provides such attributes, and it is further distinguished by its inclusion of repeated questionnaire and medical tests for half of the participants. Second, the cohort’s longitudinal data collection provides a unique opportunity to analyse temporal and causal associations between risk factors, chronic diseases and cancer, and to tease apart confounding factors via stratified analysis of sub-populations. Third, the unique and highly efficient infrastructure for participant enrolment, data collection, medical testing and follow-up, within the framework of a world-leading health screening centre, coupled with the existing large database and biorepository, make this cohort extremely cost-efficient. Fourth, there are ∼ 17 000 participants with two generations and ∼ 26 000 participants with three generations enroled in the cohort, allowing family-based studies. Moreover, the number of participants is continuously increasing on a daily basis. One weakness is that the participants are membership based and may have slightly higher socioeconomic status (SES) than general the Taiwan population; however, the prevalence of risk factors and incidence and mortality rates of cancer in this cohort are comparable to those in the general Taiwan population (data not shown). Another weakness is the retrospective nature of the data collection relying on recall from earlier years of development, which may lead to recall bias. The Taiwan MJ Cohort is available to the worldwide research community and offers collaboration. Applicants for data access should contact the MJ Health Research Foundation at [http://www.mjhrf.org/]. The cohort was established as part of a massive health screening system by a private firm, MJ Health Management Institution, Taipei, Taiwan. More than 500 000 adults, age 20 and above, were successively recruited, starting 1994. All participants were encouraged to visit on a yearly basis. The 17-year study period yielded 5.97 million person-years of follow-up. The dataset comprises individual data concerning health history, lifestyle, standard panel of blood tests, urine, stool, lung function, vision and hearing, cardiograms, physical fitness and physical examination, and linkage to the National Death file and National Cancer Registry file. Applicants for data access should contact MJ Health Research Foundation [http://www.mjhrf.org/], the source of data. Access to cohort resources for collaborative research may be requested through the data and biospecimen access committee that reviews and prioritizes all research projects for approval. Grant support: Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital. The funding source had no role in study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit the paper for publication. Raw data used for analysis in this research were received from MJ Health Resource Center. Authorization Code: MJHRFB2014001C. The MJ Health Resource Foundation is responsible for the data distribution. Any interpretation or conclusions drawn from the research analysis does not represent the views of MJ Health Resource Center. Conflict of interest: C.K.T. owns the health surveillance company whose data were provided by him for this study, but C.K.T. was not involved in the actual writing of the manuscript.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: